Moderna Shares Drop As Political Picture Worsens
In This Article:
Moderna laid out plans Thursday to slash future costs in an effort to stop bleeding cash, but a worsening political environment for vaccine companies is making its plan a tough sell. Moderna stuck by its prior guidance and reported a quarterly loss of $2.52 a share; the consensus estimate was a per-share loss of $3.12. Revenue was $108 million, in line with the $106 million consensus estimate.
Terms and Privacy Policy